Skip to contentE
Escalon Medical Corp
E
ESMCEscalon Medical Corp Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$3.47M$3.47Mderived+10.7% vs Q4 2023 Net Income$134.41K$134.41Kderived−32.2% vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Escalon Medical Corp · CIK 862668 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived$138,303−32.5% Operating Cash Flowderived-$339,871N/M Free Cash Flowderived-$349,118N/M Margins · derivedOperating margin4.0%−2.6 pt vs Q4 2023
Net margin3.9%−2.5 pt vs Q4 2023
ended Jun 30, 2024 · filed Sep 30, 2024 · 92 d after period end